Skip to main content
TipRanks
Go Ultimate75% OFF

Yakuodo Holdings Co., Ltd. (7679) AI Stock Analysis

1 Followers
JP:7679

Yakuodo Holdings Co., Ltd.

(TSE/TYO:7679)

Select Model
Rating:57Neutral
Price Target:JPY 1,500.00â–¼(-0.33% Downside)
Action:reiterated
Date:11/07/26

The score is primarily constrained by weakening cash-flow quality (including negative free cash flow in 2026) and higher balance-sheet risk from the latest debt increase, alongside a clearly bearish technical trend (price below major moving averages). These are partly offset by an attractive low P/E valuation and steady top-line growth with stable (but thin) profitability.

Positive Factors
Consistent Revenue GrowthA multi-year record of revenue growth indicates continued customer demand across the drugstore network and supports the durability of the local retail model. Although growth moderated in 2026, sustained expansion provides a foundation for maintaining scale and funding ongoing operations.
Negative Factors
Sharp Debt IncreaseThe latest debt step-up increases financial risk relative to the company’s earlier moderate-leverage profile. Higher obligations can reduce flexibility during weaker trading periods and may constrain the funds available for store investment, expansion, or other strategic priorities.

Yakuodo Holdings Co., Ltd. (7679) vs. iShares MSCI Japan ETF (EWJ)

-40%-30%-20%-10%0%10%20%30%JP:7679-29.37%EWJ+15.75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 29.82B
Dividend Yield
1.93%
Average Volume (3M)
71.88K
Price to Earnings (P/E)
7.9
Beta (1Y)
0.38
Revenue Growth
8.08%
EPS Growth
-15.52%
Country
Japan
Employees
1,094
Sector
General
Sector Strength
55
Industry
Medical - Pharmaceuticals

Yakuodo Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

YAKUODO HOLDINGS Co., Ltd., through its subsidiaries, engages in drugstore business in Japan. It retails health products, including energy drinks, cold medicine, disposable diapers for nursing care, and sanitary products; beauty products comprising s...

Yakuodo Holdings Co., Ltd. Financial Statement Overview

Summary

Income statement trends are solid (consistent revenue growth and stable profitability), but overall financial quality is held back by balance-sheet and cash-flow concerns: a sharp rise in debt in 2026 and volatile, recently deteriorating free cash flow (negative in 2026) reduce financial flexibility.

Income Statement

74Positive

Balance Sheet

62Positive

Cash Flow

44Neutral
Financial statement breakdown
BreakdownTTMFeb 2025Feb 2024Feb 2023Feb 2022Feb 2021
Income Statement
Total Revenue170.75B163.81B151.96B142.24B128.79B110.53B
Gross Profit33.02B31.71B29.66B27.86B25.45B23.27B
EBITDA9.04B8.97B8.71B8.16B7.56B7.36B
Net Income3.73B4.03B4.28B3.83B3.24B3.29B
Balance Sheet
Total Assets118.97B103.17B80.26B71.07B68.01B60.90B
Cash, Cash Equivalents and Short-Term Investments18.80B10.01B7.17B4.95B5.28B9.14B
Total Debt37.87B34.60B18.19B13.60B15.75B16.30B
Total Liabilities77.07B62.94B43.19B37.75B38.06B35.87B
Stockholders Equity41.90B40.23B37.06B33.31B29.94B25.02B
Cash Flow
Free Cash Flow0-8.28B569.00M3.58B2.76B955.00M
Operating Cash Flow03.29B4.49B5.63B6.41B5.21B
Investing Cash Flow0-12.84B-4.57B-2.27B-4.11B-4.98B
Financing Cash Flow012.40B2.30B-3.69B-1.27B6.95B

Yakuodo Holdings Co., Ltd. Technical Analysis

Technical Analysis SentimentNeutral
Last Price1505.00

Price Trends

50DMA1572.02Negative
100DMA1637.30Negative
200DMA1763.98Negative

Market Momentum

MACD-24.59Negative
RSI47.04Neutral
STOCH54.24Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7679, the sentiment is Neutral. The current price of 1505.00 is above the 20-day moving average (MA) of 1500.05, below the 50-day MA of 1572.02, and below the 200-day MA of 1763.98, indicating a neutral trend. The MACD of -24.59 indicates Negative momentum. The RSI at 47.04 is Neutral, neither overbought nor oversold. The STOCH value of 54.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7679.

Yakuodo Holdings Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7679 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3391JP:339181OutperformJPY 1.13T19.417.13%1.91%――
JP:7649JP:764969NeutralJPY 528.15B16.799.94%1.30%8.97%-29.54%
JP:9989JP:998969NeutralJPY 452.96B14.3711.15%3.43%4.32%0.18%
JP:3549JP:354962NeutralJPY 486.01B25.22―0.29%12.54%15.87%
JP:3349JP:334960NeutralJPY 502.83B15.48―1.31%8.99%3.61%
JP:7679JP:767957NeutralJPY 29.59B7.93―1.93%8.08%-15.52%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-20%0%20%JP:7679JP:9989JP:7649JP:3391JP:3349JP:3549Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7679 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7679Yakuodo Holdings Co., Ltd.1505.00-618.89-29.14%
JP:9989Sundrug Co 3848.00-263.45-6.41%
JP:7649Sugi Holdings Co 1345.00-419.08-23.76%
JP:3391TSURUHA Holdings 2455.50-241.32-8.95%
JP:3349COSMOS Pharmaceutical Corporation6236.00-1078.62-14.75%
JP:3549KUSURI NO AOKI HOLDINGS CO.,LTD.5084.001137.9628.84%

Yakuodo Holdings Co., Ltd. Corporate Events

Yakuodo October Sales Rise 6.8% as Store Network Expands

Nov 5, 2026

Yakuodo Holdings reported October 2026 sales growth across its store network, with total sales rising 6.8% year on year, customer numbers increasing 5.5% and average spending climbing 1.2%. Existing-store sales grew 1.1%, supported by a 1.6% increase...

Yakuodo grows sales but sees profit slide and leverage rise in first half

Oct 5, 2026

Yakuodo Holdings reported consolidated net sales of ¥89.76 billion for the six months ended August 31, 2026, an 8.4% year-on-year increase, but operating profit fell 5.3% to ¥3.29 billion and profit attributable to owners declined 11.8% to ¥2.23 bill...

Yakuodo’s September Sales Stay Strong as Drugstore Chain Expands to 469 Stores

Oct 5, 2026

Yakuodo Holdings Co., Ltd. reported solid sales momentum for September 2026, with all-store net sales up 8.5% year on year and existing-store sales rising 3.1%. Growth was driven by both higher customer numbers and increased average spending, extendi...

Yakuodo’s August Flash Report Shows Solid Sales and Ongoing Regional Expansion

Sep 4, 2026

Yakuodo Holdings reported that all-store net sales for March through August of the fiscal year ending February 28, 2027 rose between 2.9% and 12.5% year on year, supported by growth in both customer numbers and average spending. Existing stores also...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026